Product image of Milgamma (Benfotiamine, Pyridoxine Hydrochloride) supplied by GNH India

Milgamma

Active Ingredient:
Benfotiamine, Pyridoxine Hydrochloride
Origin:
EU

Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine and Pyridoxine Hydrochloride, the active ingredient in Milgamma, is a Vitamin B1 (thiamine) derivative and Vitamin B6 presented as a nutritional supplement for oral use. It supports peripheral nerve health, helps manage diabetic neuropathy symptoms, and prevents vitamin B1/B6 deficiency.

GNH India supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Milgamma, containing benfotiamine and pyridoxine, is used to support peripheral nerve health and carbohydrate metabolism in conditions related to vitamin B1/B6 deficiency.

  • Diabetic neuropathy: may alleviate sensory symptoms and improve nerve function.
  • Vitamin B1 deficiency (beriberi): restores intracellular thiamine phosphate levels.
  • Vitamin B6 deficiency: supports amino‑acid metabolism and neurotransmitter synthesis.

How It Works

  • Benfotiamine is a lipid‑soluble thiamine pro‑drug that is converted intracellularly to thiamine diphosphate, enhancing glucose metabolism and limiting advanced glycation end‑product formation. Pyridoxine hydrochloride provides vitamin B6, acting as a co‑factor for enzymes involved in amino‑acid transamination, neurotransmitter production, and hemoglobin synthesis, thereby supporting nerve and metabolic health.

Side Effects

Milgamma is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects

  • Nausea: mild stomach upset after ingestion.
  • Abdominal discomfort: transient bloating or cramping.
  • Headache: occasional mild headache.
  • Skin rash: mild erythema or itching.
  • Dizziness: brief light‑headedness.
  • Altered taste: temporary metallic sensation.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical care.
  • Stevens‑Johnson syndrome: rare severe skin eruption.
  • Liver enzyme elevation: abnormal hepatic function tests.
  • Blood dyscrasias: uncommon changes in blood cell counts.
  • Pancreatitis: rare inflammation of the pancreas.
  • Worsening neuropathy: unexpected increase in nerve pain.

Precautions & Warnings

Before initiating Milgamma, consider the following safety measures.

  • Assess vitamin status: evaluate baseline B1/B6 levels when possible.
  • Monitor glucose: observe blood sugar control in diabetic patients.
  • Renal impairment: adjust use if significant kidney dysfunction is present.
  • Hypersensitivity: discontinue if any allergic reaction occurs.
  • Pregnancy/Breastfeeding: consult a healthcare professional before use.
  • Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Milgamma may interact with certain medicines; awareness helps avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Levodopa therapy: pyridoxine can diminish levodopa effectiveness.
  • High‑dose thiamine supplements: may cause thiamine excess when combined.
  • Certain chemotherapy agents: concurrent use may mask neuropathy symptoms.

Moderate Interactions (Monitor Closely)

  • Anticonvulsants (e.g., phenobarbital): increase vitamin B6 metabolism.
  • Oral contraceptives: may raise vitamin B6 requirement.
  • Diuretics: enhance excretion of water‑soluble vitamins.
  • Alcohol consumption: augments risk of B6 deficiency.
  • Antacids: can reduce absorption of pyridoxine.

Frequently Asked Questions

Milgamma is a nutritional supplement that combines benfotiamine (a vitamin B1 derivative) and pyridoxine hydrochloride (vitamin B6). It is used to support peripheral nerve health, help manage symptoms of diabetic neuropathy, and prevent deficiencies of vitamins B1 and B6.

Benfotiamine is a lipid‑soluble pro‑drug of thiamine. After oral absorption, it is converted inside cells to thiamine diphosphate, which participates in carbohydrate metabolism and reduces the formation of harmful advanced glycation end‑products, thereby protecting nerve tissue.

The appropriate dose of Milgamma is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, renal function, and other factors. Patients should follow the prescriber’s instructions and not self‑adjust the dosage.

Safety data for Milgamma in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using the product.

To place an order, submit an enquiry on the Milgamma product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Milgamma combines benfotiamine, a highly bioavailable thiamine pro‑drug, with pyridoxine hydrochloride, offering both enhanced cellular uptake and a broad spectrum of B‑vitamin activity. Compared with standard thiamine or pyridoxine tablets, the benfotiamine component may provide superior support for glucose‑related pathways and nerve protection.

Milgamma should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Milgamma is taken orally, usually with water. The tablet or capsule should be swallowed whole and not chewed or crushed unless directed by a healthcare professional.

Serious but rare risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, significant liver enzyme elevations, and blood dyscrasias. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or unexplained fatigue.

Individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the formulation should avoid Milgamma. Additionally, patients with severe renal impairment or those taking medications that may interact significantly (e.g., levodopa) should consult their physician before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Benfotiamine, Pyridoxine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT